Whytee,
Placebo, RCT trial, Control arm trial etc etc. No longer a relevant consideration given that BSI and the COC appear to have accepted the data, trial and protocols as presented by Oncosil, and evidenced by BSI’s Positive Status Report which was issued in October 2019.
Cheers,
GW
- Forums
- ASX - By Stock
- OSL
- Ann: Half Yearly Report and Accounts
OSL
oncosil medical ltd
Add to My Watchlist
3.48%
!
97.0¢

Ann: Half Yearly Report and Accounts, page-83
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
97.0¢ |
Change
-0.035(3.48%) |
Mkt cap ! $13.79M |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 97.0¢ | $66.41K | 66.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3907 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3907 | 0.970 |
1 | 1000 | 0.960 |
3 | 2600 | 0.950 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 3000 | 1 |
1.000 | 4000 | 1 |
1.020 | 2000 | 1 |
1.045 | 1249 | 1 |
1.050 | 25000 | 1 |
Last trade - 15.47pm 23/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |